Clinical trial
A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
NCT00002246 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002246 |
|---|---|
| Title | A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex |
| Official title | A Pilot Open Label, Multicenter Study to Evaluate the Role of Stavudine (d4T) in the Treatment of AIDS Dementia Complex |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | AIDS Dementia Complex, HIV Infections |
| Intervention type | Drug |
| Interventions | Stavudine |
| Enrollment | 20 |
| Start date | Oct 1, 1997 |
| Primary completion | Mar 1, 1999 |
| Completion | Mar 1, 1999 |
| First posted | Aug 31, 2001 |
| Last update posted | May 4, 2011 |
| Countries | Australia, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: